Trial Site Detail
Drug: |
XL820 |
|||
|---|---|---|---|---|
Trial: |
Study of XL820 Given Orally Daily to Subjects With Solid Tumors |
|||
| Conditions: | Cancer | |||
Trial Status: |
Completed |
|||
The Cancer Institute of New Jersey195 Little Albany St. |
Principal Investigator: |
Mark Stein, MD |
|---|---|
Contact: |
Pamela Scott 732-235-7459 scottpd@umdnj.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
The Cancer Institute of New Jersey Website: |
http://www.cinj.org/clinical_trials/index.html |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.